Alder BioPharmaceuticals Inc (ALDR)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

11804 NORTH CREEK PARKWAY SOUTH BOTHELL, WA 98011

Alder Biopharmaceuticals, Inc. provides pharmaceutical products and services. The Company offers identifies, develops, and manufactures antibody therapeutics to alleviate human suffering in cancer, pain, cardiovascular, and autoimmune and inflammatory disease areas. Alder Biopharmaceuticals operates in the United States.

View SEC Filings from ALDR instead.
Q1 2020 All Institutions Hedge Funds 1
No data found for this quarter.
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ALDR (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ALDR BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

TPG GROUP HOLDINGS (SBS) ADVISORS, INC.

BONDERMAN DAVID

COULTER JAMES G

  • 10% Owner
18,798,075 2020-07-29 0

REDMILE GROUP, LLC

GREEN JEREMY

  • 10% Owner
0 2020-07-29 1

NOVO HOLDINGS A/S

  • 10% Owner
2,569,379 2020-07-28 0

SIEGALL CLAY B PRESIDENT AND CEO

  • Officer
  • Director
718,339 2020-07-08 1

PAKIANATHAN DEEPIKA

  • Director
0 2020-07-01 0

PRESTON HEATHER

  • Director
8,823 2020-06-30 1

MONTGOMERY ALAN BRUCE

  • Director
0 2020-06-25 1

CARTER ERIC G

  • Director
0 2020-06-23 0

YARNO WENDY L

  • Director
0 2020-06-18 1

AZELBY ROBERT

  • Director
3,718 2020-06-18 1

SANDOVAL ELISABETH

  • Director
0 2020-06-12 0

BRIDGER GARY

  • Director
0 2020-06-10 0

CARTER PAUL RUTHERFORD

  • Director
20,320 2020-05-13 1

CAMPOY CARLOS CHIEF FINANCIAL OFFICER

  • Officer
0 2020-03-23 1

H LUNDBECK A S

  • 10% Owner
522,499 2020-03-16 2

SMITH JEFFREY T L MANAGING DIRECTOR

  • Officer
0 2019-10-22 2

HASSLER RANDAL EVP, PHARMACEUTICAL OPS.

  • Officer
0 2019-10-22 1

CLEVELAND PAUL B

  • Director
0 2019-10-22 1

BUCHER JAMES B EVP & GENERAL COUNSEL

  • Officer
0 2019-10-22 1

LAVELLE ERIN CHIEF OPERATING OFFICER

  • Officer
0 2019-10-22 1

STRECK PAUL CHIEF MEDICAL OFFICER

  • Officer
0 2019-10-22 1

DAC NADIA CHIEF COMMERCIAL OFFICER

  • Officer
0 2019-10-22 1

BENEDICT LARRY EVP AND PAO

  • Officer
39,728 2019-04-23 0

LITTON MARK JAMES SEE REMARKS

  • Officer
0 2019-02-06 0

LATHAM JOHN A CHIEF SCIENTIFIC OFFICER

  • Officer
244,180 2019-02-06 0

BISGAARD PETER

  • Director
0 2018-06-28 0

SCHATZMAN RANDALL C PRESIDENT AND CEO

  • Officer
  • Director
0 2018-02-16 0

DOW STEPHEN M

  • Director
307,190 2017-07-18 0

WHITAKER TIMOTHY M CHIEF MEDICAL OFFICER

  • Officer
0 2017-01-27 0

SRB ASSOCIATES IX L.P.

SEVIN ROSEN FUND IX L.P.

SEVIN ROSEN IX AFFILIATES FUND L.P.

  • AFFILIATEAFFILIATEAFFILIATE
No longer subject to file 2015-08-31 0

JAGGERS JOHN V

BAYLESS JON W

DOMENIK STEPHEN L

KIMZEY JACKIE R

MCLEAN DAVID J.

OXAAL JOHN T

SCHUELE ALAN R

STURIALE NICHOLAS G

  • AFFILIATEAFFILIATEAFFILIATEAFFILIATEAFFILIATEAFFILIATEAFFILIATEAFFILIATE
1,849,885 2015-08-11 0

DAVIDSON AARON

  • Director
2,581,976 2014-05-13 0

H.I.G. VENTURE PARTNERS II, L.P.

H.I.G. VENTURES - ALDER, LLC

  • 10% Owner
516,395 2014-05-13 0

DELPHI MANAGEMENT PARTNERS VII, L.L.C.

DELPHI VENTURES VII L P

DELPHI BIOINVESTMENTS VII LP

PAKIANATHAN DEEPIKA

ROEDER DOUGLAS A

DOUGLASS DAVID L

BOCHNOWSKI JAMES J

  • Director
  • 10% Owner
2,838,532 2014-05-13 0

VENTURES WEST 8 LIMITED PARTNERSHIP

  • 10% Owner
3,469,528 2014-05-13 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions
Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments